Skip to content

Digestibility of Different Plant-based Proteins in Humans With Ileostomy

True Ileal Digestibility of Different Plant-based Proteins in a Human Ileostomy Model

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06142084
Acronym
PAN-Prodig
Enrollment
11
Registered
2023-11-21
Start date
2026-09-01
Completion date
2028-12-01
Last updated
2026-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ileostomy - Stoma

Keywords

Protein, Plant-based, Digestibility

Brief summary

The goal of this interventional study is to learn about the digestibility of different plant-based proteins in adults (age 18-75) with an ileostomy. The main questions the study aims to answer are: 1. How does the digestibility of proteins in the small intestine differ between different plant-based proteins? 2. Which proteins and amino acids are not digested or absorbed in the small intestine and are available for further metabolic processes in the large intestine? 3. How do metabolites in the collected content of the ileostomy bag differ after consuming different plant-based proteins? 4. Can the in vivo results be compared to results from existing in vitro models? Participants will consume five different protein meals (oat protein - high bioavailable, oat protein - low bioavailable, pea protein - high bioavailable, pea protein low bioavailable, protein-free meal) on five different study days in a random order. Five hours after consuming the test meals ileostomy bags will be collected and the content will be analysed to answer the above mentioned research questions.

Interventions

DIETARY_SUPPLEMENTOat Protein, low bioavailability

Participants will consume a protein meal consisting of cooked whole oat kernels (amount based on body weight, 0.3g of protein/kg bodyweight).

DIETARY_SUPPLEMENTOat Protein, high bioavailability

Participants will consume a protein meal consisting of heated oat protein concentrate (amount based on body weight, 0.3g of protein/kg bodyweight).

DIETARY_SUPPLEMENTPea Protein, low bioavailability

Participants will consume a protein meal consisting of cooked whole yellow peas (amount based on body weight, 0.3g of protein/kg bodyweight).

DIETARY_SUPPLEMENTPea Protein, high bioavailability

Participants will consume a protein meal consisting of heated pea protein isolate (amount based on body weight, 0.3g of protein/kg bodyweight).

DIETARY_SUPPLEMENTProtein-free meal

Participants will consume a protein-free meal to correct analyses for endogenous protein losses.

Sponsors

Örebro University, Sweden
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age: 18 - 75 years * Body mass index: 18.5 - 30 kg/m2 * (double-loop) Ileostomy with an intact small bowel * Signed informed consent

Exclusion criteria

* Pregnancy or breastfeeding * Ileostomy \< 3 months before the study * Any clinically significant present or past disease/condition other than colon cancer which in the investigator's opinion could interfere with the results of the trial * Any clinically significant present or past medication which in the investigator's opinion could interfere with the results of the trial

Design outcomes

Primary

MeasureTime frameDescription
True ileal digestibility of different plant-based proteins0-5 hours after consumption of test meal (on all 5 study days)The primary outcome is defined as the differences in the true ileal digestibility, determined by measuring the amount of nitrogen in the meal and the amount of unabsorbed nitrogen in the ileal fluid after consuming four different plant-based protein meals

Secondary

MeasureTime frameDescription
Protein and metabolite profiles in ileostomy digesta0-5 hours after consumption of test meal (on all 5 study days)The secondary outcomes are defined as changes in protein and metabolite profiles in the digesta, determined by proteomics and metabolomic analyses.
Differences between in vivo and in vitro dataIn vivo data: 0-5 hours after consumption of test meal (on all 5 study days)Results from the human ileostomy model will be compared with results from in vitro digestion according to the Infogest 2.0 protocol for each of the tested plant-based proteins

Countries

Sweden

Contacts

CONTACTRobert Brummer, PhD
robert.brummer@oru.se004619303731
CONTACTAnnalena Kamm, MSc
annalena.kamm@oru.se0046790676822

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 24, 2026